Last updated 2 years ago

Efficacy and Safety of Tanzânia Association in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia

262 patients around the world

Available in Brazil

EMS

262Patients around the world

Requirements for the patient

From 18 Years

Male

: Ability to confirm voluntary participation and agree to all trial purposes by signing and dating the informed consent forms;
Male participants aged 18 years or more;
Sexually active participants with a defined partner who have averaged 1 attempt at sexual intercourse per week in the past month;
Diagnosis of Benign Prostatic Hyperplasia;
Diagnosis of erectile dysfunction;
Patients with score between 6 and 25 points in the erectile function questionnaire;
IPSS (International Prostate Symptom Score) greater or equal to 8 points;

: Known hypersensitivity to the formula components used during the clinical trial;
History of alcohol and/or substance abuse within 2 years;
Diagnosis of other diseases or conditions in the urinary tract, including but not limited to: cancer, neurogenic bladder; urinary incontinence, recurrent infection, urethral stricture, bacterial prostatitis;
Clinical evidence of prostate cancer;
Hypogonadism or absent sexual desire;
Severe psychiatric or psychosocial disorders;
Primary erectile dysfunction;
Polyneuropathy, neurodegenerative diseases, trauma or spinal cord injuries, central nervous system tumors or other conditions that may affect erections;
Anatomical penile deformation that can significantly impair erection, including but not limited to: angulation, cavernous fibrosis, Peyronie's disease.

SponsorEMS

Study typeInterventional

Requirements

From 18 YearsMale

Unique study IDclinicaltrials.gov

NCT04185441